Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Plos One|July 30, 2015
High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-HydroxydopamineD Luke Fischer, Timothy J Collier, Allyson Cole-Strauss, et al.
Molecular Therapy. Methods & Clinical Development|December 10, 2016
Impact of age and vector construct on striatal and nigral transgene expressionNicole K Polinski, Fredric P Manfredsson, Matthew J Benskey, et al.
Acta Neuropathologica Communications|January 21, 2025
Distinct subcellular localization of tau and alpha-synuclein in lewy body diseaseD Luke Fischer, Marissa Menard, Omar Z Abdelaziz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisCarolina Bidó Bello, D Luke Fischer, Agathe Vrillon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2017
Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional RestorationD Luke Fischer, Christopher J Kemp, Allyson Cole-Strauss, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 20, 2020
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseD Luke Fischer, Peggy Auinger, John L Goudreau, et al.
Neurobiology of Disease|November 14, 2020
The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in ratsNatosha M Mercado, Jennifer A Stancati, Caryl E Sortwell, et al.
Neuromodulation : Journal of the International Neuromodulation Society|July 21, 2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseCaryl E Sortwell, Mallory L Hacker, David Luke Fischer, et al.
Scientific Reports|November 29, 2017
Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein OverexpressionD Luke Fischer, Fredric P Manfredsson, Christopher J Kemp, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 28, 2024
Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohortNiyatee Samudra, D Luke Fischer, Steven Lenio, et al.
Pageof 3